Customise Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorised as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site.... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyse the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customised advertisements based on the pages you visited previously and to analyse the effectiveness of the ad campaigns.

No cookies to display.

Doximity Shares Soar 25% After Company Beats on Revenue, Raises Fiscal-Year Guidance

Doximity at the New York Stock Exchange for Its Initial Public Offering on June 24, 2021.

Source: Nyse

Shares of Doximity Popped 25% in Extended Trading on CHURSDAY After The Company Reported Third -Quarter Fiscal 2025 Results that Beat Analysts’ Expectations for Revenue and Offred Rosy Guidance.

Here’s how the company did:

  • Earnings per share:45 cents adjusted vs. 34 cents expected by lseg
  • Revenue: $ 168.6 Million vs. $ 152.8 Million Expected By Lseg

Doximity is a digital platform for medical professionals The company primarily generates revealed its telehealth tools, hiring solutions and marketing offerings for clients such as Pharmaceutical Companies.

Doximity’s Revenue Increased 25% in Its Third Quarter from $ 135.3 Million during the same period last year, according to a release,

For its fiscal fourth quarter, doximity said it expects to report revelationue between $ 132.5 million and $ 133.5 million, Compared with Analysts’ Estimates of $ 123.83.83.83.8 million.

The company also raised guidance for its full fiscal year, and said it expects to report reverene Last QuarterWhen it expected $ 535 million to $ 540 million. Analysts was expecting $ 540 million for the year.

“We’re Proud to Deliver Another Quarter of Record Engagement in Q3, with Over 610,000 Unique Providers Using Our Clinical Workflow Tools,” Doximity CEO JEFFFF TANGNEY SAID In A Statement. “Our Ai Tools Grew The Fastest Last Quarter, Up 60% Over the Prior Quarter, While Our NewsFeed Surpassed More Than One Million Unique Providers.”

The company reported net income of $ 75.2 million, or 37 cents per share, during its third Quarter, Up from from $ 48.0 Million, or 24 cents per share, a year prior. Doximity’s Adjusted Ebitda was $ 102.0 Million, Up 39% Year Over Year.

Doximity has been a bright spot within the Battered Digital Health Sector, which has decided a Reckoning as companies have had to adjust to a More MUmed Growth Environment. The company’s stock price more than doubled in 2024.

Don’t miss these insights from CNBC Pro

(Tagstotranslate) Doximity inc (T) Health Care Industry (T) Internet (T) Social Media (T) Technology (T) Technology (T) Breaking News: Technology (T) Business News

Source link

Leave a Comment